Recursion Pharmaceuticals Inc (RXRX)
8.58
-0.06
(-0.69%)
USD |
NASDAQ |
May 10, 16:00
8.87
+0.29
(+3.38%)
After-Hours: 20:00
Recursion Pharmaceuticals Market Cap: 2.013B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.027B |
| May 08, 2024 | 2.016B |
| May 07, 2024 | 2.063B |
| May 06, 2024 | 2.098B |
| May 03, 2024 | 2.074B |
| May 02, 2024 | 2.063B |
| May 01, 2024 | 1.957B |
| April 30, 2024 | 1.835B |
| April 29, 2024 | 1.924B |
| April 26, 2024 | 1.905B |
| April 25, 2024 | 1.840B |
| April 24, 2024 | 1.863B |
| April 23, 2024 | 1.807B |
| April 22, 2024 | 1.783B |
| April 19, 2024 | 1.725B |
| April 18, 2024 | 1.736B |
| April 17, 2024 | 1.753B |
| April 16, 2024 | 1.776B |
| April 15, 2024 | 1.828B |
| April 12, 2024 | 1.973B |
| April 11, 2024 | 2.093B |
| April 10, 2024 | 2.013B |
| April 09, 2024 | 2.133B |
| April 08, 2024 | 2.112B |
| April 05, 2024 | 2.081B |
| Date | Value |
|---|---|
| April 04, 2024 | 2.049B |
| April 03, 2024 | 2.095B |
| April 02, 2024 | 2.058B |
| April 01, 2024 | 2.199B |
| March 28, 2024 | 2.339B |
| March 27, 2024 | 2.386B |
| March 26, 2024 | 2.422B |
| March 25, 2024 | 2.471B |
| March 22, 2024 | 2.462B |
| March 21, 2024 | 2.499B |
| March 20, 2024 | 2.598B |
| March 19, 2024 | 2.523B |
| March 18, 2024 | 2.680B |
| March 15, 2024 | 2.633B |
| March 14, 2024 | 2.530B |
| March 13, 2024 | 2.576B |
| March 12, 2024 | 2.473B |
| March 11, 2024 | 2.433B |
| March 08, 2024 | 2.626B |
| March 07, 2024 | 2.616B |
| March 06, 2024 | 2.656B |
| March 05, 2024 | 2.795B |
| March 04, 2024 | 2.886B |
| March 01, 2024 | 3.006B |
| February 29, 2024 | 3.158B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
866.92M
Minimum
May 11 2022
6.961B
Maximum
Jul 13 2021
2.336B
Average
1.864B
Median
Aug 18 2022
Market Cap Benchmarks
| Eli Lilly and Co | 722.44B |
| Palatin Technologies Inc | 36.63M |
| Oragenics Inc | 8.245M |
| Actinium Pharmaceuticals Inc | 260.01M |
| Marinus Pharmaceuticals Inc | 73.61M |
Market Cap Related Metrics
| PS Ratio | 40.55 |
| PEG Ratio | -0.3744 |
| Price to Book Value | 4.344 |
| Price | 8.58 |
| Earnings Yield | -18.30% |
| PEGY Ratio | -0.3744 |